{"symbol": "EARS", "companyName": "Auris Medical Holding AG", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.aurismedical.com", "description": "Auris Medical Holding AG is a clinical-stage biopharmaceutical company. It is engaged in the development of novel products for the treatment of inner ear disorders. Its product candidate is AM-101.", "CEO": "Thomas Meyer", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}